168 related articles for article (PubMed ID: 37216470)
1. Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery.
Ko JA; Komatsu K; Minamoto A; Kondo S; Okumichi H; Hirooka K; Kiuchi Y
Curr Eye Res; 2023 Sep; 48(9):826-835. PubMed ID: 37216470
[TBL] [Abstract][Full Text] [Related]
2. An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor.
Ibrahim DG; Ko JA; Iwata W; Okumichi H; Kiuchi Y
Cell Biochem Funct; 2019 Mar; 37(2):113-124. PubMed ID: 30773659
[TBL] [Abstract][Full Text] [Related]
3. The effects of ripasudil (K-115), a Rho kinase inhibitor, on activation of human conjunctival fibroblasts.
Futakuchi A; Inoue T; Fujimoto T; Inoue-Mochita M; Kawai M; Tanihara H
Exp Eye Res; 2016 Aug; 149():107-115. PubMed ID: 27394186
[TBL] [Abstract][Full Text] [Related]
4. Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery.
Honjo M; Tanihara H; Kameda T; Kawaji T; Yoshimura N; Araie M
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5549-57. PubMed ID: 18055804
[TBL] [Abstract][Full Text] [Related]
5. Rho kinase inhibitor AMA0526 improves surgical outcome in a rabbit model of glaucoma filtration surgery.
Van de Velde S; Van Bergen T; Vandewalle E; Kindt N; Castermans K; Moons L; Stalmans I
Prog Brain Res; 2015; 220():283-97. PubMed ID: 26497796
[TBL] [Abstract][Full Text] [Related]
6. AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery.
Cheng WS; Chen CL; Chen JT; Lin LT; Pao SI; Chen YH; Lu DW
Molecules; 2020 Sep; 25(19):. PubMed ID: 32993110
[TBL] [Abstract][Full Text] [Related]
7. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
Meyer-ter-Vehn T; Sieprath S; Katzenberger B; Gebhardt S; Grehn F; Schlunck G
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4895-904. PubMed ID: 17065504
[TBL] [Abstract][Full Text] [Related]
8. Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials.
Tanihara H; Inoue T; Yamamoto T; Kuwayama Y; Abe H; Suganami H; Araie M;
JAMA Ophthalmol; 2015 Jul; 133(7):755-61. PubMed ID: 25880207
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.
Clement Freiberg J; von Spreckelsen A; Kolko M; Azuara-Blanco A; Virgili G
Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013817. PubMed ID: 35686679
[TBL] [Abstract][Full Text] [Related]
10. SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism.
Xiao YQ; Liu K; Shen JF; Xu GT; Ye W
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1698-706. PubMed ID: 19098325
[TBL] [Abstract][Full Text] [Related]
11. SPARC is expressed in scars of the Tenon's capsule and mediates scarring properties of human Tenon's fibroblasts in vitro.
Fuchshofer R; Kottler UB; Ohlmann AV; Schlötzer-Schrehardt U; Jünemann A; Kruse FE; Ohlmann A
Mol Vis; 2011 Jan; 17():177-85. PubMed ID: 21264231
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase (ROCK) Inhibitors - A Neuroprotective Therapeutic Paradigm with a Focus on Ocular Utility.
Abbhi V; Piplani P
Curr Med Chem; 2020; 27(14):2222-2256. PubMed ID: 30378487
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of heat shock protein 47 suppressed collagen production in Tenon's capsule fibroblasts.
Wang W; lI H
Folia Histochem Cytobiol; 2023; 61(3):153-159. PubMed ID: 37724035
[TBL] [Abstract][Full Text] [Related]
14. Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study.
Mizuno Y; Okada N; Onoe H; Tokumo K; Okumichi H; Hirooka K; Kiuchi Y
BMC Ophthalmol; 2022 Nov; 22(1):433. PubMed ID: 36376831
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts.
Liu Y; Kimura K; Orita T; Suzuki K; Teranishi S; Mori T; Sonoda KH
Mol Vis; 2015; 21():1368-77. PubMed ID: 26788029
[TBL] [Abstract][Full Text] [Related]
16. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent.
Cordeiro MF; Gay JA; Khaw PT
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2225-34. PubMed ID: 10476787
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate (EGCG) inhibits myofibroblast transformation of human Tenon's fibroblasts.
Lin HL; Qin YJ; Zhang YL; Zhang YQ; Chen YL; Niu YY; Pang CP; Chu WK; Zhang HY
Exp Eye Res; 2020 Aug; 197():108119. PubMed ID: 32603658
[TBL] [Abstract][Full Text] [Related]
18. Additive Intraocular Pressure-Lowering Effects of Ripasudil with Glaucoma Therapeutic Agents in Rabbits and Monkeys.
Kaneko Y; Ohta M; Isobe T; Nakamura Y; Mizuno K
J Ophthalmol; 2017; 2017():7079645. PubMed ID: 28540083
[TBL] [Abstract][Full Text] [Related]
19. p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts.
Meyer-Ter-Vehn T; Gebhardt S; Sebald W; Buttmann M; Grehn F; Schlunck G; Knaus P
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1500-9. PubMed ID: 16565385
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Chitosan/Aptamer Targeting TGF-β Receptor II Thermo-Sensitive Gel for Scarring in Rat Glaucoma Filtration Surgery.
Zhu X; Xu D; Zhu X; Li L; Li H; Guo F; Chen X; Tan Y; Xie L
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5465-76. PubMed ID: 26284552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
